Zscaler to Host Third Quarter Fiscal Year 2025 Earnings Conference Call
Earnings Results to be Released on Thursday, May 29, After the Close of the Market Earnings Results to be Released on Thursday, May 29, After the Close of the Market ...
Enphase Energy Announces Easy Expansion of IQ7 Solar Systems with IQ8 Microinverters
FREMONT, Calif., May 08, 2025 ( GLOBE NEWSWIRE ) -- Enphase Energy, Inc. ( NASDAQ: ENPH ) , a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the availability of new software that allows homeowners with existing ...
Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update
NEW YORK, May 08, 2025 ( GLOBE NEWSWIRE ) -- Protara Therapeutics, Inc. ( Nasdaq: TARA ) , a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced financial results for the first quarter ended March 31, 2025, and provided a ...
FOREWARN to Provide Identity Verification Services to NEXUS Association of REALTORS® to Promote Agent Safety
New Jersey-based Association contracts to make FOREWARN services available for its 5,000+ real estate professional members to promote proactive agent safety New Jersey-based Association contracts to make FOREWARN services available for its 5,000+ real estate professional members to promote ...
Equity Prime Mortgage Unveils Star-Studded Lineup for The American Gift ( TAG ) 2025 Featuring Kevin Hart, T-Pain, and Dave Portnoy
Eddy Perez, Founder & CEO, Brings Faith, Community, and Celebration to Mercedes-Benz Stadium this June
Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update
BOSTON, May 08, 2025 ( GLOBE NEWSWIRE ) -- Compass Therapeutics, Inc. ( Nasdaq: CMPX ) , a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today reported first quarter 2025 financial results and provided a business update.
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
IND clearance and initiation of global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren's disease, idiopathic inflammatory myopathies and systemic sclerosis ...
Merus to Present at BofA Securities 2025 Health Care Conference
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 08, 2025 ( GLOBE NEWSWIRE ) -- Merus N.V. ( Nasdaq: MRUS ) , an oncology company developing innovative, full-length multispecific antibodies ( Biclonics® and Triclonics® ) , today announced that Bill Lundberg, M.D., President, Chief Executive ...
The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates
CERRITOS, Calif., May 08, 2025 ( GLOBE NEWSWIRE ) -- The Oncology Institute, Inc. ( NASDAQ: TOI ) ( "TOI" ) , one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcoming ASCO Annual Meeting further ...
